World Heart warns of Nasdaq delisting:
This article was originally published in Clinica
Executive Summary
Canadian ventricular assist device company World Heart has been told it is subject to a delisting from the Nasdaq national market as it is currently failing to meet the required minimum market value of publicly held securities for continued listing. The Ottawa, Ontario-based company is taking appropriate actions and plans an appeal, it says.